[1]刘晓青,任伊宁,兴 伟,等.疏肝理气方对浆细胞性乳腺炎患者术后恢复及免疫因子的影响[J].陕西中医,2024,(7):926-929.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.014]
　LIU Xiaoqing,REN Yining,XING Wei,et al.Effects of Shugan Liqi on recovery and immune factors of patients with plasma cell mastitis after operation[J].,2024,(7):926-929.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.014]
点击复制

疏肝理气方对浆细胞性乳腺炎患者术后恢复及免疫因子的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年7期
页码:
926-929
栏目:
临床研究
出版日期:
2024-07-05

文章信息/Info

Title:
Effects of Shugan Liqi on recovery and immune factors of patients with plasma cell mastitis after operation
作者:
刘晓青1; 任伊宁1; 兴 伟1; 周 伟2
(1.河北中医药大学第一附属医院普外科,河北 石家庄 050011; 2.刚果民主共和国中刚友谊医院,金沙萨利明得区 999059)
Author(s):
LIU Xiaoqing; REN Yining; XING Wei; ZHOU Wei
(Department of General Surgery,First Affiliated Hospital of Hebei University of Chinese Medicine,Shijiazhuang 050011,China)
关键词:
浆细胞性乳腺炎;  乳痈;  疏肝理气;  清热解毒;  免疫因子;  分化簇3;  分化簇4
Keywords:
Plasma cell mastitis;  Ruyong;  Shugan Liqi;  Qingre Jiedu;  Immune factor;  Differentiation cluster 3;  Differentiation cluster 4
分类号:
R 271.1
DOI:
DOI:10.3969/j.issn.1000-7369.2024.07.014
文献标志码:
A
摘要:
目的:分析浆细胞性乳腺炎(PCM)患者应用疏肝理气、清热解毒法对其术后恢复及免疫因子的影响。方法:选取PCM术后患者88例,以随机方式分为两组。对照组采用常规西医疗法,研究组在对照组基础上应用中药疏肝理气、清热解毒法治疗,比较两组患者恢复情况、免疫因子指标变化及不良反应、并发症发生情况。结果:研究组治疗总有效率高于对照组(P<0.05)。与对照组比较,研究组的术后引流时间、拆线时间、切口愈合时间、住院时间更短(P<0.05)。两组换药时间比较,差异无统计学意义(P>0.05)。两组术后当天疼痛视觉模拟评分(VAS)比较,差异无统计学意义(P>0.05)。研究组术后3 d及术后7 d的VAS评分低于对照组,差异有统计学意义(均P<0.05)。与对照组比较,研究组术后7 d的血清分化簇3(CD3+)、分化簇4(CD4+)、CD4+/分化簇8(CD8+)CD8+更高,而CD8+更低,差异有统计学意义(均P<0.05)。两组不良反应、并发症发生率比较,差异无统计学意义(均P>0.05)。结论:对PCM术后患者应用中药疏肝理气、清热解毒法较单纯西药治疗更利于促进患者恢复,减轻疼痛,促进免疫功能恢复,且安全性较好。
Abstract:
Objective:To analyze effects of Shugan Liqi,Qingre Jiedu on recovery and immune factors in patients with plasma cell mastitis(PCM)after operation.Methods:88 patients with PCM were randomly divided into two groups.The control group received conventional western medicine therapy.On the basis of the control group,the study group were treated with traditional Chinese medicine Shugan Liqi,Qingre Jiedu.The recovery,changes of immune factors and occurrence of adverse reactions complications were compared between the two groups.Results:The effective rate of the study group was higher than that in the control group(P<0.05).Compared with the control group,the postoperative drainage time,suture removal time,incision healing time and hospital stay in the study group were shorter(P<0.05).There was no significant difference in dressing change time between the two groups(P>0.05).There was no significant difference in visual analogue scale(VAS)between the two groups on the day after surgery(P>0.05).The VAS scores of the study group were lower at 3 and 7 days after surgery(P<0.05).Serum differentiation cluster 3(CD3+),differentiation cluster 4(CD4+),CD4+/differentiation cluster 8(CD8+)were higher and CD8+ were lower in the study group 7 days after surgery.There was no significant difference in the incidence of adverse reactions complications between the two groups(P>0.05).Conclusion:Compared with western medicine alone,the application of TCM Shugan Liqi and Qingre Jiedu in patients with PCM after operation were more beneficial to promote recovery of patients,relieve pain and promote recovery of immune functionand better safety.

参考文献/References:

[1] ZHENG Y,WANG L,HAN X,et al.Combining contrast-enhanced ultrasound and blood cell analysis to improve diagnostic accuracy of plasma cell mastitis[J].Exp Biol Med,2022,247(2):97-105.
[2] MOHAMMED A A.Mammary duct ectasia in adult femalesrisk factors for the diseasea case control study[J].Ann Med Surg,2021,62:140-144.
[3] MOON S,LIM H S,KI S Y.Ultrasound findings of mammary duct ectasia causing bloody nipple discharge in infancy and childhood[J].Journal Ultrasound Med,2019,38(10):2793-2798.
[4] 张允申,刘海红,方勇,等.疏肝解毒汤治疗浆细胞乳腺炎疗效及对炎症因子和免疫功能的影响[J].中华中医药杂志,2021,36(6):3732-3735.
[5] 朴明姬,许斌,杜金柱,等.清热活血解毒方联合改良挂线术治疗瘘管期浆细胞性乳腺炎临床研究[J].陕西中医,2022,43(3):305-308.
[6] 中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学.非哺乳期乳腺炎诊治专家共识[J].中国实用外科杂志,2016,36(7):755.
[7] 马民,张桂娟.中医外科学[M].广州:暨南大学出版社出版,2015:150.
[8] JIANG L,LI X,SUN B,et al.Clinicopathological features of granulomatous lobular mastitis and mammary duct ectasia[J].Oncol Lett,2020,19(1):840-848.
[9] ALI M M.Diagnosis and surgical treatment of pathologic nipple discharge using ultrasound-guided wire localization of focal ductal dilatation[J].Breast Journal,2020,26(2):139-143.
[10] 邱国春,冷婕,万霞,等.疏肝消肿散治疗肝郁痰凝型肉芽肿性乳腺炎的临床疗效及对患者体液免疫指标和炎症指标水平的影响[J].河北中医,2021,43(7):1123-1126,1131.
[11] 乔楠,丁晓雯,吴金娜,等.倪毓生运用疏肝散结汤加减分期治疗肉芽肿性乳腺炎合并下肢结节性红斑验案3则[J].江苏中医药,2023,55(8):53-56.
[12] 王雨青,孙霃平,刘胜.从“乳为肝窍”论治乳房疾病[J].陕西中医,2022,43(7):929-131,949.
[13] 赵赟,王浩然,李少康,等.王万林“阴阳为纲,以通为用”治疗浆细胞性乳腺炎经验[J].中国中医基础医学杂志,2023,29(3):491-494.
[14] 高晴倩,万华,吴雪卿,等.清化痰湿方联合盾构切开术对浆细胞性乳腺炎患者术后创面愈合、疾病复发的影响[J].陕西中医,2020,41(11):1556-1558.
[15] 王月,周亮,孙涛,等.疏肝理气、化瘀通络法治疗肿块期肉芽肿性乳腺炎疗效观察[J].现代中西医结合杂志,2021,30(23):2550-2554.
[16] 李晓菲,董梦婷,帕提古丽?加帕尔,等.基于中医传承辅助平台探究含柴胡-郁金药对乳腺癌治疗方剂的组方规律[J].辽宁中医杂志,2022,49(9):24-28.
[17] 甘霖,熊志峰,杨化超,等.瓜蒌柴胡汤加减联合中药外治法对郁滞期乳痈患者炎症因子的影响[J].中国中医急症,2021,30(6):1010-1012.
[18] 秦淼,刘新军,王春霞.中医治疗浆细胞性乳腺炎28例[J].四川中医,2008,26(5):72-73.
[19] 钱南南,魏涛华,唐露露,等.黄芪溯源考证及其改善认知功能研究进展[J].辽宁中医药大学学报,2021,23(12):108-111.
[20] 付豹,王进峰,刘晓飞,等.万应膏外敷联合手术对浆细胞性乳腺炎病人炎性因子、免疫因子及细胞间黏附分子-1、可溶性细胞间黏附分子-1的影响[J].安徽医药,2021,25(7):1319-1323.
[21] 罗彦斌,唐玉宁,肖宁,等.微通道与标准通道经皮肾镜取石术对肾结石治疗的临床疗效及安全性[J].国际泌尿系统杂志,2021,41(5):815-819.
[22] 张帅,刘胜,孙霃平.基于数据挖掘技术的中医药治疗浆细胞性乳腺炎用药规律研究[J].上海中医药杂志,2017,51(4):23-29.
[23] 姜雪冰,王知斌,孙延平,等.东北蒲公英根的化学成分研究[J].中成药,2023,45(6):1887-1891.
[24] 葛亚梅,彭双立,陈俊.“黄芪-丹参-山楂”治疗2型糖尿病合并非酒精性脂肪性肝病的作用机制研究[J].中西医结合肝病杂志,2023,33(4):337-342.
[25] 左斌,夏晓枫,车彪,等.虎杖苷对小鼠腰椎间盘退变髓核细胞凋亡及SIRT1/mTOR通路的影响[J].中国组织工程研究,2021,25(35):5619-5625.

相似文献/References:

[1]高晴倩,万 华,吴雪卿,等.清化痰湿方联合盾构切开术对浆细胞性乳腺炎患者术后创面愈合、疾病复发的影响*[J].陕西中医,2020,(11):1556.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.010]
[2]张 普,陈震霖,陈羽佩,等.论肉芽肿性乳腺炎的因机证治[J].陕西中医,2022,(1):97.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.024]
　ZHANG Pu,CHEN Zhenlin,CHEN Yupei,et al.Etiology,pathogenesis and treatment of granulomatous mastitis[J].,2022,(7):97.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.024]
[3]朴明姬,许 斌,杜金柱,等.清热活血解毒方联合改良挂线术治疗瘘管期浆细胞性乳腺炎临床研究[J].陕西中医,2022,(3):305.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.008]
　PIAO Mingji,XU Bin,DU Jinzhu,et al.Clinical study on the treatment of fistula plasma cell mastitis with Qingre Huoxue Jiedu prescription combined with modified suture hanging[J].,2022,(7):305.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.008]
[4]王雨青,孙霃平,刘 胜.从“乳为肝窍”论治乳房疾病[J].陕西中医,2022,(7):929.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.028]
　WANG Yuqing,SUN Chenping,LIU Sheng.Discussion on the treatment of breast disease from the theory based on “breast is the opening of liver”[J].,2022,(7):929.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.028]
[5]牛莹超,任伊宁,兴 伟.疏肝清热方联合微创清创法治疗浆细胞性乳腺炎肝经郁热证临床研究[J].陕西中医,2024,(3):349.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.013]
　NIU Yingchao,REN Yining,XING Wei.Clinical study on treatment of plasma cell mastitis liver meridian stagnation heat type with Shugan Qingre formula combined with minimally invasive debridement[J].,2024,(7):349.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.013]

备注/Memo

备注/Memo:
基金项目:河北省中医药管理局科研计划项目(2023043)
更新日期/Last Update: 2024-07-09